Article info

Download PDFPDF
Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis
  1. D Aletaha, Division of Rheumatology, Medical University of Vienna, Waehringer Guertel 18–20, 1090 Vienna, Austria; daniel.aletaha{at}meduniwien.ac.at
View Full Text

Citation

Karonitsch T, Aletaha D, Boers M, et al
Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis

Publication history

  • Accepted June 5, 2008
  • First published September 12, 2008.
Online issue publication 
September 12, 2008

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.